Overview
Portfolio
More
Nina Capital
Barcelona, Spain
We invest in early‑stage health‑technology companies that combine deep domain knowledge of the healthcare system with advanced data, AI and information‑technology solutions. Our focus is on need‑driven founders building...
Portfolio
54+
Employees
25+
Founded
2019
AUM
≈ $110.0M
Investment focus
Stages
Pre-Seed → Series A
Industries
Artificial IntelligenceData & AnalyticsDigital HealthHealthcare Technology
Geographic scope
AustraliaCanadaEuropeIsraelUnited States
Fund details
Funds
Fund III
Vintage 2025 • $55.0
Check sizes
Min: $220.0K
Typical: $935.0K
Max: $1.7M
Sources
Nina Capital
We invest in early‑stage health‑technology companies that combine deep domain knowledge of the healthcare system with advanced data, AI and information‑technology solutions. Our focus is on need‑driven founders building products that improve clinical and economic outcomes across the care continuum, with a pan‑European and global ambition.
Portfolio
54+
Employees
25+
Founded
2019
AUM
≈ $110.0M
Funds
Fund III · Vintage 2025 • $55.0
Check Sizes
Min: $220.0K
Typical: $935.0K
Max: $1.7M
Stages
Pre-Seed → Series A
Industries
Artificial IntelligenceData & AnalyticsDigital HealthHealthcare Technology
Geographic scope
AustraliaCanadaEuropeIsraelUnited States
Sources
Showing 24 of 51 matched portfolio companies
Adora is a digital health platform that utilizes natural language processing (NLP) and artificial intelligence (AI) to provide personalized menopause support for women in the workplace. The platform offers direct access to gynecologists, a symptom tracker, and educational resources, addressing the lack of tailored health guidance during menopause, which affects a significant portion of the workforce.
Provides an AI-driven platform, ObesityRx™, that analyzes patient medical histories to identify personalized, evidence-based treatment strategies for obesity and related metabolic conditions. This data-centric approach improves clinical decision-making, balances treatment costs, and supports sustainable health outcomes by integrating seamlessly into value-based care models.
Funding: $2.1M
Rough estimate of the amount of funding raised
Funding: $2.1M
Rough estimate of the amount of funding raised
basys.ai provides enterprise-grade Generative AI solutions specifically for the healthcare industry. The platform automates complex workflows such as prior authorization, utilization management, and payment integrity processes. This technology delivers high clinical accuracy and significantly accelerates decision-making times for payers and providers.
20+
3K+Approximate amount of employees
Funding: $2.5M
Rough estimate of the amount of funding raised
Healthworx Accelerator
Healthworx Accelerator
Funding: $2.5M
Rough estimate of the amount of funding raised
The startup operates a biomedical data analysis platform that provides end-to-end bioinformatics solutions, including access to datasets, analytic workflows, and cloud-computing infrastructure. This platform enables researchers and companies to efficiently transform raw experimental data into actionable insights for new treatments and diagnostics, thereby accelerating the pace of scientific discovery.
Funding: $600.0K
Rough estimate of the amount of funding raised
Funding: $600.0K
Rough estimate of the amount of funding raised
CalmiGo is a patented device that utilizes personalized breathing regulation, multi-sensory stimulation, and calming scents to provide immediate, drug-free relief from anxiety, panic attacks, and PTSD. The technology activates the parasympathetic nervous system, effectively reducing stress hormone levels within three minutes, making it suitable for users aged six and up.
Funding: $10.0K
Rough estimate of the amount of funding raised
Funding: $10.0K
Rough estimate of the amount of funding raised
The startup develops cloud-based artificial intelligence software for cardiac data analysis, utilizing proprietary algorithms validated against arrhythmia and clinical datasets. This technology provides healthcare providers with clear, actionable reports that enhance diagnostic accuracy and streamline clinical workflows.
Connective Health utilizes AI and clinical interoperability to automate the retrieval of outside medical records, creating tailored patient summaries that integrate directly into existing EHR workflows. This technology reduces the time required for medical record access, enabling providers to deliver timely, informed care based on a patient's complete medical history.
Funding: $4.2M
Rough estimate of the amount of funding raised
Funding: $4.2M
Rough estimate of the amount of funding raised
contextflow develops AI imaging technology for chest CT scans, providing radiologists with tools for nodule detection, quantification, and tracking, as well as lung tissue analysis. This technology enhances diagnostic accuracy and efficiency by reducing false positives and streamlining the reporting process for lung cancer, interstitial lung disease, and chronic obstructive pulmonary disease cases.
Funding: $10.1M
Rough estimate of the amount of funding raised
Funding: $10.1M
Rough estimate of the amount of funding raised
CryoCloud offers a web-based platform providing instant access to cloud resources and optimized image analysis workflows for cryo-electron microscopy (cryo-EM) data processing. This service eliminates infrastructure setup, hardware maintenance, and job queues by leveraging on-demand, high-performance computing. Researchers gain simplified, accelerated access to industry-standard tools like Relion, enabling faster protein structure determination and collaborative project management.
Funding: $540.0K
Rough estimate of the amount of funding raised
Nina Capital
Nina Capital
Funding: $540.0K
Rough estimate of the amount of funding raised
DataJoint provides a programmable data‑science platform that links laboratory instruments, code, and multimodal datasets into version‑controlled, relational workflows. It automatically tracks provenance, runs containerized analysis pipelines on local, HPC, or cloud resources, and offers built‑in quality‑control, fine‑grained access controls, and modular “Elements” for common biomedical assays.
Funding: $4.9M
Rough estimate of the amount of funding raised
Capital FactoryInoca Capital
Capital FactoryInoca Capital
Funding: $4.9M
Rough estimate of the amount of funding raised
Datamonk.ai offers an AI-powered migration platform that automates data mapping, script generation, and cleansing, significantly reducing migration timelines from months to days. The solution addresses the challenges of slow, costly, and error-prone data migration projects by ensuring high data quality and minimizing reliance on manual processes.
EarlySight provides the Cellularis platform, an ophthalmic camera that uses adaptive‑optics trans‑scleral flood illumination to capture cellular‑resolution images of the retina and optic disc, revealing structures invisible to standard devices. The system offers multi‑mode imaging, widefield fundus registration, and joystick‑controlled fast acquisition, enabling ophthalmologists and researchers to detect, monitor, and assess eye disease biomarkers more precisely.
Funding: $3.9M
Rough estimate of the amount of funding raised
Verve Ventures
Verve Ventures
Funding: $3.9M
Rough estimate of the amount of funding raised
Elypta is developing a metabolism-based liquid biopsy platform that analyzes glycosaminoglycan profiles in blood samples to detect cancer signatures noninvasively. This technology enables early cancer detection and monitoring, potentially identifying individuals at high risk up to six years before diagnosis.
Funding: $29.8M
Rough estimate of the amount of funding raised
The Roddenberry Foundation
The Roddenberry Foundation
Funding: $29.8M
Rough estimate of the amount of funding raised
The startup operates a mental healthcare platform that provides a structured case formulation tool, enabling individuals to articulate their situations and share them with therapy professionals. This approach allows healthcare providers to efficiently identify and address patients' core issues and goals from the outset of treatment.
Funding: $960.0K
Rough estimate of the amount of funding raised
Nina Capital
Nina Capital
Funding: $960.0K
Rough estimate of the amount of funding raised
Healee provides a configurable patient access solution that optimizes scheduling and communication across healthcare organizations, enhancing capacity utilization and reducing no-show rates. By integrating with existing EHR systems, it streamlines patient navigation and facilitates over 700,000 visits monthly, ensuring compliance with state licensure requirements.
Funding: $25.0K
Rough estimate of the amount of funding raised
Transform
Transform
Funding: $25.0K
Rough estimate of the amount of funding raised
Hypercare provides a secure communication platform that enables clinical teams to quickly locate and connect with the appropriate on-call providers in real-time, thereby enhancing care coordination. This solution addresses inefficiencies in communication and reduces the risk of medical errors by consolidating call schedules and facilitating immediate access to critical information.
The startup operates an online telehealth platform that provides monthly medication management services, featuring a smart pill dispenser designed to minimize medication errors. This solution specifically assists patients with reduced mobility in organizing and adhering to their medication schedules.
Funding: $492.0K
Rough estimate of the amount of funding raised
Funding: $492.0K
Rough estimate of the amount of funding raised
This company provides an AI platform that integrates directly into existing EMR systems to enhance home health documentation accuracy. The platform offers real-time guidance to clinicians, significantly reducing OASIS errors and documentation rework for QA teams. This results in faster chart completion, improved functional scoring, and accelerated cash flow for home health agencies.
30+
1K+Approximate amount of employees
The startup operates a text-based virtual assistant platform that utilizes conversational AI and optional human support to assist patients with chronic conditions in managing their health. This tool enhances care coordination and navigation, improving medication adherence and health outcomes for value-based care providers and payers.
Leuko Labs is developing PointCheck™, a non-invasive device that uses light to monitor white blood cell levels by imaging blood cells in superficial capillaries. This technology enables frequent testing for millions of immunosuppressed patients, reducing the risk of infection without the need for blood draws.
Funding: $4.5M
Rough estimate of the amount of funding raised
National Cancer Institute
National Cancer Institute
Funding: $4.5M
Rough estimate of the amount of funding raised
LillianCare addresses healthcare gaps in underserved regions by integrating modern healthcare professionals into primary care settings. The company adapts established international models to redistribute medical treatment responsibilities among physicians, Physician Assistants, and nurses. This approach aims to improve physician availability and accelerate patient treatment within the German healthcare system.
Magentiq Eye LTD develops the MAGENTIQ-COLO System, an AI-powered platform for automatic polyp detection and analysis during colonoscopy procedures. This technology enhances adenoma detection rates, significantly reducing the risk of colorectal cancer by improving diagnostic accuracy and clinical decision-making in gastroenterology.
The startup offers a healthcare logbook platform that consolidates training materials, feedback, and certification documents into a single digital repository. This platform enables healthcare professionals and students to efficiently manage their educational resources, enhancing organization and accessibility in their training processes.
30+
3K+Approximate amount of employees
Funding: $4.0M
Rough estimate of the amount of funding raised
Connect Ventures
Connect Ventures
Funding: $4.0M
Rough estimate of the amount of funding raised
MedaSystems provides a cloud platform designed to streamline expanded and managed access programs for life science companies. This system accelerates approval decisions, reduces manual administrative tasks, and ensures regulatory compliance for investigational medicine distribution. The platform facilitates better collaboration between pharmaceutical teams and healthcare providers while capturing essential real-world data.
Debiopharm Innovation Fund
Showing 3 of 3 unmatched portfolio companies